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Abstract
Purpose: Central venous access ports (CVAP) are widely used to provide long-term vascular access for the delivery 
of chemotherapeutic medications. The aim of this study was to evaluate the clinical outcomes and complications 
following CVAP implantation in the interventional radiology suite. 
Material and methods: A retrospective analysis was conducted on 937 oncology patients who underwent CVAP im-
plantation between January 2009 and June 2017. Information regarding patient characteristics, operative data, and 
procedural outcomes was collected and analysed.
Results: A total of 937 patients scheduled for CVAP were included in the final analysis. Initial success was achieved 
in 930 patients (99.3%), and overall completion was achieved in 933 patients (99.6%). There were 63 complications 
overall. Among these, 19 (2.0%) occurred during the intra- and perioperative period and 44 were late complications 
(4.7%). No CVAP-related mortalities were observed.
Conclusions: The analysis in the present study revealed that the CVAP is a safe and effective route for long-term 
administration of chemotherapy with an overall complication rate of 6.7% throughout the entire device duration. 
The CVAP implantation procedure carried out in the interventional radiology suite provides an advantage in the 
management of procedural, vascular and catheter-related complications. 
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complications.
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Introduction
Intensive methods used in the administration of chemother-
apeutic medications has increased the need for implantable 
devices that provide long-term vascular access. The sig-
nificant venous toxicity of chemotherapeutic drugs often 
results in the rapid termination of peripheral access [1]. 
Central venous access ports (CVAP) are associated with 
reduced venous toxicity during prolonged courses of 
chemotherapy, playing an essential role in improving the 
patient’s quality of life in modern oncology [2-4]. This 
retrospective study analyses the experience of the CVAP 
implantation procedure in a large sample of oncology pa-
tients, considering procedural success rate, complications 
and their management. 
Material and methods
Patient population
Between January 2009 and June 2017, 937 patients un-
derwent CVAP implantation in the Department of Diag-
nostic and Interventional Radiology at Poznan University 
of Medical Sciences. A total of 940 CVAP implantation 
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procedures were performed in 937 oncology patients. In-
clusion criteria for this study were that all patients had 
documented active malignancy and had CVAP implanted 
for chemotherapy administration. Detailed demographic 
data are shown in Table 1. All patients were treated with 
intravenous chemotherapy as a mainstay or adjunctive 
therapy in primary neoplastic diseases, or presented meta-
static lesions. The most common diagnosis was colorectal 
cancer (48.3%), followed by breast (25.3%), gastric (7.3%), 
and pancreatic carcinoma (4.5%). Difficulties concerning 
peripheral venous access were the initial primary indica-
tion for implantation. Later, CVAP implantation became 
a standard procedure in all patients scheduled for long-
term systemic chemotherapy. 
Data analysis
Information regarding the age, gender, site of primary tu-
mour, operative data, complications, and outcome of the 
implantation procedure within the patient population 
was retrospectively collected. The follow-up period for 
this study for each patient lasted from the date of CVAP 
insertion until the date of scheduled device removal, 
death, or the last recorded date. Initial success of the pro-
cedure was defined as one resulting in maintained aspi-
ration and infusion throughout the system and properly 
healed surgical wounds at the time of the second session 
of chemotherapy administration. Overall completion rate 
describes the number of patients who had CVAP success-
fully implanted, despite any initial procedure failure. Any 
complication occurring within the period before the sec-
ond chemotherapy session was defined as an early com-
plication, while complications occurring after the second 
chemotherapy session were defined as late complications. 
Central venous access ports placement procedure
CVAP placement procedures were performed in the in-
terventional radiology suite. A single model of port was 
used in all cases (Celsite, B. Braun, Boulogne-Billancourt, 
France). Each patient received oral premedication with 
7.5 mg of midazolam and 1 g of prophylactic IV cefazolin 
prior to the procedure. The second dose of cefazolin was 
administered 12 hours after the first dose. The subclavian 
vein (SCV) was the initial choice of vascular access for 
introducing the port. The internal jugular vein (IJV) or 
brachiocephalic vein (BCV) was chosen if unsuccessful 
attempts at subclavian puncture occurred, or if SCV ste-
nosis, compression or occlusion was suspected, based on 
anamnesis and clinical examination. Direct puncture us-
ing the Seldinger method was performed according to an-
atomical landmarks, mostly without ultrasound guidance 
or pre-procedural imaging of the central veins. 
CVAP were subcutaneously implanted under local an-
aesthesia. A single-lumen catheter was inserted through 
the guide wire at the puncture site and the tip was placed 
at the level of the cavoatrial junction, confirmed under 
fluoroscopy. The pouch for the port reservoir was dissect-
ed into the subcutaneous tissue of the chest wall. The cath-
eter was tunnelled under the skin from the pouch to the 
venous entry site and subsequently inserted into the vena 
cava superior. The port reservoir was then immobilised 
with sutures in the subcutaneous tissue. Initially, the cath-
eter length was precisely measured on fluoroscopy and cut 
to the correct length in the pouch. Later, a technique con-
sisting of aligning the catheter with a properly positioned 
guidewire was developed, allowing the proper measure-
ment of the required catheter length and preparation 
of a suitable catheter with the port outside of the body. 
Afterwards the entire system was inserted at once, which 
made the procedure quicker and more convenient. After 
the subcutaneous dissolvable sutures had been placed, 
post-procedural digital subtraction angiography (DSA) 
was performed to evaluate port integrity and post-oper-
ative flow through the system. Finally, the reservoir was 
aspirated and flushed with a heparinised saline solution. 
Table 1. Patient characteristics and diagnosis
Characteristic
Number of patients 937
Age, years 













Sarcoma MSK 14 (1.5)
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A chest X-ray was carried out up to 12 hours after im-
plantation to confirm the correct position of the CVAP 
and the catheter tip, and to rule out possible complica-
tions such as pneumothorax. 
Complication management 
Early complications such as pneumothorax were managed 
with catheter drainage in symptomatic cases or when the 
pneumothorax was larger than 3 cm on the chest X-ray. 
The CVAP placement procedure was discontinued in cas-
es when the patient’s general condition was poor, prior 
to liquid transfusions, blood pressure normalisation and 
medical symptom management. Inadvertent arterial punc-
ture was a minor issue, which was not found to be a true 
complication. It was satisfactorily treated with short-term 
compression of the punctured area. Inadvertent sheath in-
sertion into the brachiocephalic artery in one case prompt-
ed its immediate removal with occlusion balloon control 
and preparation of a covered stent in case of uncontrolled 
bleeding (Figure 1). Bleeding from a ruptured internal 
thoracic artery occurred in one case in which the sheath 
was inadvertently removed. This was managed with bal-
loon occlusion and subsequent implantation of a coronary 
covered stent (Figure 2). Early infection was another indi-
cation for port removal and subsequent antibiotic therapy.
The management of late complications, such as cath-
eter occlusion, was carried out using the “pull-and-push” 
technique with saline infusion until the proper flow was 
restored. Angiography was performed when port mal-
function was suspected. In cases concerning disturbed 
infusion, the immobilised catheter tip was snared through 
the femoral access site, and subsequently released and 
repositioned away from the fibrin sheath (Figure 3). 
A case of pinch-off syndrome and catheter rupture was 
managed with endovascular therapy. The loose catheter 
fragment in this case was snared and removed through 
the femoral access site. Another CVAP implantation was 
carried out using the BCV access site. DVT complications 
were managed with anticoagulation. Port infection was 
managed initially with antibiotic infusions through the 
port system, and the ports were scheduled for removal in 
cases in which symptom relief was not achieved.
Ethics
In accordance with Polish law and good clinical practice 
(GCP) regulations, this retrospective analysis did not re-
quire approval of the Bioethics Committee of Poznan Uni-
versity of Medical Sciences. The methods described in this 
article were carried out in accordance with the guidelines 
and regulations of our institution. Informed consent was 
acquired from all patients before the procedure. 
Data availability statement
All data generated or analysed during this study are in-
cluded in this published article (and its Supplementary 
Information files).
Results
Primary technical success of CVAP placement was 
achieved in 99.3% (930/937) of patients. In 7 patients, 
Figure 1. A) Peel-away sheath inadvertently inserted into the ascending aorta through the brachiocephalic artery (asterisk). B) External compression 
together with balloon catheter (arrows) to control the vascular injury site after sheath removal. C) Control digital subtraction angiography – no neurologic 
complications, no extravasation, patency of the arteries
A B C
 Central venous access ports in the interventional radiology
e331© Pol J Radiol 2019; 84: e328-e334
initial implantation failure occurred. In 3 cases, the pa-
tients’ poor general condition prompted discontinuation 
of the procedure (vasovagal syncope, nausea/vomiting, 
allergic reaction to the prophylactic antibiotic) that pre-
vented completion of the procedure. In two cases, inad-
vertent arterial puncture and sheath insertion occurred. 
In one of these cases, the sheath was removed carelessly, 
resulting in massive bleeding from the ruptured internal 
thoracic artery, which led to haemothorax and circulatory 
shock. The complication was treated endovascularly and 
the patient fully recovered. In the other case, the sheath 
was removed safely with angiographic control using end-
ovascular techniques for guidance, causing no bleeding. 
The two patients technically had successful implantations, 
but the ports had to be removed within a few days due to 
signs of infections. Three of the patients with initial port 
implantation failure underwent successive port implanta-
tion procedures. The overall completion rate was 99.6% 
(933/937) (Table 2). 
The access route used for implantation was the SCV 
in 839 patients, the IJV in 40 patients and the BCV in 
60 patients. Initial subclavian access was unsuccessful in 
Figure 2. A) Digital subtraction angiography of right subclavian artery. Ruptured right internal thoracic artery in 2 spots (arrows) with massive bleeding. 
B) Temporary bleeding control with angioplasty balloon catheter (asterisk). C) Final extravasation control with coronary covered stents (arrowheads)
A B C
Figure 3. A) Port malfunction with disturbed aspiration and altered injection/infusion performance. Tip of the catheter (asterisk) located in the “fibrin 
sheath” in vena cava superior. B) Port catheter (arrows) captured from femoral vein access site. C) Reposition of the port catheter. Control angiography – 
undisturbed, free flow through the port system
A B C
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18 (1.9%) patients. For these patients, CVAP were suc-
cessfully implanted via the IJV or the BCV. Eighty-five 
percent of ports were placed on the right side of the chest. 
The mean surgical time was 21.7 minutes (standard devia-
Table 3. Early and late complications 
Early complications (out of 940) No. (%)
Pneumothorax 12 (1.3)
Arterial rupture and massive bleeding 1 (0.1)
Inadvertent arterial sheath placement 1 (0.1)
Clinical status disabling procedure completion
Vasovagal syncope 1 (0.1)
Vomiting, nausea 1 (0.1)
Nausea, hypotension, allergic reaction to prophylactic 
antibiotic
1 (0.1)
Early port infection 2 (0.2)
Total 19/940 (2.0)
Late complications (out of 933) No. (%)
Catheter occlusion 13 (1.4)
Deep venous thrombosis 7 (0.8)
Port infection 7 (0.8)
Catheter malfunction 16 (1.7)
Catheter rupture 1 (0.1)
Total 44/933 (4.7)
Total complications 63 (6.7)
Table 2. Details of central venous access ports placement
Parameter 
Total number of port procedures  940
Insertion site, n (940) (%)
Subclavian vein 839 (89.3)
Brachiocephalic vein 61 (6.5)
Internal jugular vein 40 (4.3)
Right side  804 (85.5)
Left side  136 (14.5)
Procedure time, minutes 
Mean (SD) 21.7 (4.2)
Range 17-80
Known port duration 
Mean 11 months
Range 4 days – 88 months
Completion rate
Primary technical success 930/937 (99.3)
Overall completion rate 933/937 (99.6)
tion 4.2 minutes). The average time during which a CVAP 
remained in place was 11 months (range: 4 days to 88 
months). Details concerning the placement procedure 
are shown in Table 2.
CVAP complications developed in 63 implantation 
procedures (6.7%). Early complications comprised pneu-
mothorax, followed by inadvertent arterial puncture, ar-
terial sheath insertion, poor general condition, and early 
port infection (Table 3). No air embolism, early catheter 
dislocation, or port dysfunction occurred. Five out of 
12 cases of pneumothorax necessitated tube thoracostomy 
and drainage, and the rest were treated conservatively due 
to small volume and lack of progression. 
Late complications, as summarised in Table 3, oc-
curred in 4.7% (44/933) of implanted patients and includ-
ed port infection, port malfunction, deep venous throm-
bosis and catheter occlusion, dislocation or rupture. In 
16 cases, aspiration was disturbed and the quality of the 
injections was variously compromised. All of the ports 
were found to be intact and patent upon angiographic 
investigation. In 3 cases in which infusion was essential-
ly compromised, endovascular repositioning of the port 
catheter was performed and proper flow was successfully 
restored. 
Catheter occlusion was encountered in 13 cases 
(1.4%). All of them were recanalised using the “push and 
pull” injection technique with saline under fluoroscopic 
control. 
In one case, catheter rupture and dislocation (so-
called pinch-off) was observed, in which the catheter was 
dislodged into the right ventricle. The loose catheter was 
removed via snaring from the femoral vein access site, and 
the patient received a new port catheter through the bra-
chiocephalic access site.
Seven patients presented with symptoms of port in-
fection. In two of them, intravenous antibiotics and di-
rect port infusions were effective. Five patients required 
removal of the port, and two of them had a new port im-
planted in the later phase of treatment. Symptomatic DVT 
was encountered in 7 cases, and anticoagulation therapy 
was sufficient to relieve the symptoms in all cases. 
Discussion
CVAP improve the quality of life in patients by avoiding 
multiple peripheral vein punctures during prolonged 
chemotherapeutic treatment. CVAP have a decreased risk 
of causing extravasation of chemotherapeutic agents com-
pared to peripheral access, which may cause local damage 
to tissue and thrombosis and thrombophlebitis depending 
on the agent administered (e.g. 5-FU, an inflammatory 
substance). This is especially true concerning prolonged 
therapy, as the risk of extravasation increases over time 
with peripheral line infusions [2, 3, 5]. CVAP are also 
indicated for the administration of parenteral nutrition, 
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volume replacement, detoxification, and in the diagnostic 
evaluation and monitoring of patients [6]. Newer ports 
(called power ports or computed tomography-compatible 
ports) also resist high flow contrast injections when used 
in diagnostic imaging [7]. 
Placement of the catheter can be achieved through 
multiple routes. The most common access sites used are 
the IJV or SCV [4, 8, 9]. Ultrasound-guided puncture and 
surgical cut-down access through the cephalic vein at the 
deltoid-pectoralis groove are well-established alternatives 
for implantation [6]. 
The SCV was the initial site of all planned CVAP im-
plantations due to better cosmetic results and less limita-
tion of movement compared to the IJV [10]. Studies have 
reported an advantage of a shorter access time and lower 
risk of infection in long-term use associated with the SCV 
access site [5, 11, 12]. The anatomic-landmark-guided 
technique was used in this study when using the SCV ac-
cess site. This was because the ultrasound-guided catheter 
placement through the SCV access site can be complicated 
due to its anatomical location, compared to the IJV. Bony 
structures were therefore used as landmarks during the 
implantation instead of US guidance, which is the stand-
ard operating procedure in some societies [4, 13]. Eighty-
five percent of CVAP were placed on the right side of the 
chest in this study. The side of venous access was deter-
mined by the presence of unilateral breast carcinoma, the 
site of planned or completed irradiation, ulcerations on 
the chest wall, previous surgery or implanted pacemak-
er, structural anomalies, pre-existing unilateral venous 
thrombosis, or other circumstances related to personal 
preference [4, 6, 9].
Procedural complications occurring during or shortly 
after the implantation of a CVAP are mainly dependent 
on the patient status, method of implantation and local 
vascular anatomy. In this study, periprocedural complica-
tions occurred in 19 cases out of the 937 performed (2%). 
The most common intra-operative complication was 
pneumothorax (1.3%). The incidence of inadvertent ar-
terial puncture and pneumothorax experienced in this 
study was consistent with the risk rates described in other 
studies in which anatomical-landmark-guided techniques 
and subclavian vein access sites were used [9, 14]. Differ-
ent technical complications included failed puncture of 
the initially planned vein, prior to subsequent successful 
attempts at cannulation. Other complications, including 
haematoma, dyspnoea and vasovagal syncope, occurred 
less frequently (0.7% in total). 
Infection and mechanical complications represent fre-
quent and important issues that accompany the insertion 
of CVAP in cancer patients, primarily due to the nature 
of their condition. Proper training of the nurses perform-
ing infusions significantly decreases the infection rate [15, 
16]. Several of the patients presenting with signs of in-
fection were treated with antibiotics initially. When this 
did not relieve the symptoms, the patients were scheduled 
for port removal with later re-implantation. An immu-
nocompromised state, in addition to the prothrombotic 
and endothelial-damaging effect of the malignancies and 
chemotherapy, is an important risk factor. Deep venous 
thrombosis presented with ipsilateral pain and swelling in 
the arm (7 patients). The most commonly observed late 
complication in the present study was catheter occlusion, 
occurring in 13 patients (1.4%). 
Port implantation can be performed by surgeons, 
anaesthesiologists or interventional radiologists, with 
a comparable degree of procedural success [6, 17]. In this 
study, all procedures were performed in the interven-
tional radiology suite, where additional equipment and 
radiological expertise offered an advantage in the man-
agement of complications. Imaging modalities allowed for 
accurate catheter placement, short implantation time and 
the possibility of intravascular repositioning of catheters 
and recanalisation of intravenous access. 
In recent retrospective studies, complication rates 
ranged from 1.4% to 11.1% (intra-operative) and from 
6.5% to 17.1% (post-operative) [2, 4, 18]. The complica-
tion rates are comparable in this study, although a low-
er rate of complications in the late post-operative period 
was observed. Variables such as patient body mass index 
(BMI), venous access site and catheter tip location have 
been controversially discussed to be predicting factors for 
complication risk [2, 4, 16]. Observations made by other 
studies also revealed pneumothorax, infection, thrombosis 
and catheter occlusion as common complications during 
CVAP implantation [2, 4, 6]. 
Conclusions
The analysis in the present study revealed that CVAP is 
a safe and effective route for long-term administration of 
chemotherapy with an overall complication rate of 6.7% 
throughout the entire device duration. The average time 
for which the port was in place was approximately 11 
months, and the vast majority of devices remained in situ 
and complication-free until death of the patient or end of 
the treatment. The CVAP implantation procedure carried 
out in the interventional radiology suite provides an ad-
vantage in the management of procedural, vascular, and 
catheter-related complications. 
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